As our goal was to determine whether TCP was a result of resilience to AD-related pathology, using these a priori regions that are used in AD diagnosis was the clearer analysis path, but does leave open the possibility of more regionally-specific amyloid or tau differences being related to TCP. The gene discussed is MAPT; the disease is Alzheimer disease.